TLR2 and rheumatoid arthritis: In addition, an anti-TLR2 antibody has recently been demonstrated to decrease inflammation in a mouse model of arthritis [32], and blockade of TLR2 to reduce spontaneous cytokine release from synovial explant cultures in RA [33].